Add new comment

Great interview, Richard. I think what came through for me is an affirmation of the concept of universal design and that it will be harder than designing for specific groups which, ironically, may be more homogenous. Yet, I suppose both approaches are needed and there is good reason to ask whether one or the other is preferred before starting out. Like orphan drugs, "orphan products" might need support beyond the private market.